JEFFREY R SCHRIBER M.D.
Prescription History 1851369821
Internal Medicine - Hematology & Oncology in Scottsdale, AZ
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JEFFREY R SCHRIBER M.D., an active Hematology & Oncology specialist practicing in Scottsdale, AZ. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 164 documented patient claims. Among these therapy options, the most frequently utilized medication is Acyclovir, which accounts for 41 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other AZ PrescribersVs. AZ Avg |
|---|---|---|---|
| Acyclovir | 41 | $15.75▼ below AZ avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 41 Medicare prescriptions for Acyclovir, about 1.7 times the volume of the typical Arizona prescriber of this medication (24). Medicare paid an average of $15.75 per fill, versus $24.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AZ average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| PomalystPomalidomide | 33 | $21,958.23 | ≈ Typical |
About Pomalyst: Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 33 Medicare prescriptions for Pomalyst, about 1.2 times the volume of the typical Arizona prescriber of this medication (28). Medicare paid an average of $21,958.23 per fill, versus $20,765.58 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 924 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 20 | $15,634.31▼ below AZ avg | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 20 Medicare prescriptions for Revlimid, about half the volume of the typical Arizona prescriber of this medication (43). Medicare paid an average of $15,634.31 per fill, versus $18,290.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AZ average for this medication. 20 30-Day Fills standardized to 30-day supplies 553 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 18 | $20.10 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 18 Medicare prescriptions for Dexamethasone, about 67% of the volume of the typical Arizona prescriber of this medication (27). Medicare paid an average of $20.10 per fill, versus $16.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 345 Days of Medication total across all patients in 2023 | |||
| ScemblixAsciminib Hydrochloride | 18 | $16,240.69▼ below AZ avg | ▲ More than typical |
About Scemblix: Asciminib is used to treat a certain type of cancer (chronic myeloid leukemia-CML). Show more ▾ Asciminib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 18 Medicare prescriptions for Scemblix, about 1.4 times the volume of the typical Arizona prescriber of this medication (13). Medicare paid an average of $16,240.69 per fill, versus $20,533.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AZ average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 17 | $17,602.99 | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 17 Medicare prescriptions for Jakafi, about half the volume of the typical Arizona prescriber of this medication (29). Medicare paid an average of $17,602.99 per fill, versus $16,279.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 17 | $12,990.69 | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 17 Medicare prescriptions for Lenalidomide, about 89% of the volume of the typical Arizona prescriber of this medication (19). Medicare paid an average of $12,990.69 per fill, versus $12,737.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AZ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 476 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JEFFREY R SCHRIBER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Scottsdale, AZ practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among AZ prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
